Aditxt (ADTX) Operating Leases (2020 - 2026)

Aditxt (ADTX) recorded quarterly Operating Leases of $288890.0 in Q1 2026, down 15.75% quarter-over-quarter from $342904.0 in Q4 2025, and up 4.18% on a YoY basis from $277291.0 in Q1 2025.

Aditxt (ADTX) Operating Leases (2020 - 2026) Analysis & Trends

Aditxt's Operating Leases history runs 6 years deep, the most recent figure standing at $288890.0 for Q1 2026.

  • In Q1 2026, Operating Leases rose 4.18% year-over-year to $288890.0; the TTM figure through Mar 2026 stood at $288890.0 (up 4.18% YoY), while the FY2025 annual figure was $342904.0, down 21.42% from the prior year.
  • Operating Leases was $288890.0 for Q1 2026 at Aditxt, down from $342904.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $3.0 million in Q4 2022 to a low of $113357.0 in Q2 2025.
  • Historically, Operating Leases has averaged $1.0 million across 5 years, with a median of $668699.5 in 2024.
  • The sharpest annual moves came in 2025 and 2026: Operating Leases sank 84.79% in 2025, then grew 4.18% in 2026.
  • A 5-year view of Operating Leases shows it stood at $3.0 million in 2022, then tumbled by 64.95% to $1.0 million in 2023, then slumped by 58.11% to $436354.0 in 2024, then retreated by 21.42% to $342904.0 in 2025, then slipped by 15.75% to $288890.0 in 2026.
  • The last three Operating Leases figures came in at $288890.0 (Q1 2026), $342904.0 (Q4 2025), and $113357.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Aditxt 2,485.68 -2.16 Mn 2,868.00

Historic Data

Download Data
DateValue
Mar 31, 2026 288,890.00
Dec 31, 2025 342,904.00
Jun 30, 2025 113,357.00
Mar 31, 2025 277,291.00
Dec 31, 2024 436,354.00
Sep 30, 2024 592,278.00
Jun 30, 2024 745,121.00
Mar 31, 2024 891,747.00
Dec 31, 2023 1.04 Mn
Sep 30, 2023 2.29 Mn
Jun 30, 2023 2.52 Mn
Dec 31, 2022 2.97 Mn
Dec 31, 2020 858,064.00
Sep 30, 2020 865,081.00